Join us at the @Jefferies Global Healthcare Conference and the Evercore ISI 9th Annual Healthcare Conference to hear about the progress we’re making across our business and the possibilities that may be ahead for the patients we serve. $INSM
Insmed
Verified account This account is verified. Learn more@Insmed
We're a global biopharmaceutical company striving to transform the lives of patients facing serious diseases. Community guidelines: bit.ly/3DbEjVG
77 Following 2K Followers 805 Posts
Latest posts 5
Today we reported our 2026 Q3 earnings. Watch below for key highlights and read more here: bit.ly/4Bzbr7R $INSM
1:14
We're pleased to announce the appointment of Paul Hudson (former CEO of Sanofi & Novartis Pharmaceuticals) and Utpal Koppikar (CFO of Verily Health) to our Board of Directors. Their leadership strengthens our Board at a pivotal moment as we pursue our mission to transform the lives of patients with serious and rare diseases.
Read more: bit.ly/4sfNZYT
Read more: bit.ly/4sfNZYT
We’re looking forward to joining the conversation at #CHEST2026 and #IDWeek2026, sharing data that advances understanding of respiratory disease.
Learn more: bit.ly/4c5hLJb
Learn more: bit.ly/4c5hLJb
The @FDA has granted Priority Review to our supplemental New Drug Application (sNDA) for our Mycobacterium avium complex (MAC) lung disease therapy, with a target action date of January 28, 2027.
Read more: bit.ly/4c5hLJb
Read more: bit.ly/4c5hLJb